Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
This report elaborates on the current development of the Microbiome Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Symbiotix Biotherapies
Osel
Rebiotix
AOBiome
Seres Therapeutics
Metabogen
Second Genome
Ritter Pharmaceuticals
OpenBiome
Synthetic Biologics
PureTech
Interxon
Symberix
Metabiomics
Azitra
MicroBiome Therapeutics LLC
C3 Jian
4D Pharma
Enterome BioScience
Assembly Biosciences
Synlogic
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
Application:
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Microbiome Therapeutics Industry Overview
-
1.1.1 Microbiome Therapeutics Market Scope and Market Segments
-
1.1.2 Microbiome Therapeutics Industry Characteristics
-
1.1.3 Global and China Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Microbiome Therapeutics Production Value and Growth Rate (2017-2028)
-
1.2 Global Microbiome Therapeutics Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Inflammatory Bowel Disease (IBD)
-
1.2.2 Orphan Drug
-
1.2.3 Immuno-oncology
-
1.2.4 Others
-
1.3 Global Microbiome Therapeutics Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Inflammatory Bowel Disease (IBD)
-
1.3.2 Orphan Drug
-
1.3.3 Immuno-oncology
-
1.3.4 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Microbiome Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Microbiome Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Microbiome Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Microbiome Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Microbiome Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Microbiome Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Microbiome Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Microbiome Therapeutics Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Microbiome Therapeutics Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Microbiome Therapeutics Industry Porter's Five Forces Model Analysis
-
2.2.3 Microbiome Therapeutics Industry PEST Analysis
-
2.3 Microbiome Therapeutics Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Microbiome Therapeutics Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Microbiome Therapeutics Industry
Chapter 3 Global and China Microbiome Therapeutics Market, by Manufacturer
-
3.1 Global and China Microbiome Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Microbiome Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Microbiome Therapeutics Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Microbiome Therapeutics Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Microbiome Therapeutics Market Top 3 Players
Chapter 4 Global and China Microbiome Therapeutics Market, by Type (2017-2028)
-
4.1 Microbiome Therapeutics Market Trend, by Type
-
4.2 Global Microbiome Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Microbiome Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Microbiome Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Microbiome Therapeutics Price Trend, by Type (2017-2028)
-
4.3 China Microbiome Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Microbiome Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Microbiome Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Microbiome Therapeutics Price Trend, by Type (2017-2028)
Chapter 5 Global and China Microbiome Therapeutics Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Microbiome Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Microbiome Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Microbiome Therapeutics Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Microbiome Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Microbiome Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Microbiome Therapeutics Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Microbiome Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Microbiome Therapeutics Market Analysis
-
7.1 North America Microbiome Therapeutics Market, by Type
-
7.2 North America Microbiome Therapeutics Market, by Application
-
7.3 North America Microbiome Therapeutics Market Analysis and Forecast, by Country
-
7.3.1 United States Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Microbiome Therapeutics Market Analysis
-
8.1 Europe Microbiome Therapeutics Market, by Type
-
8.2 Europe Microbiome Therapeutics Market, by Application
-
8.3 Europe Microbiome Therapeutics Market Analysis and Forecast, by Country
-
8.3.1 Germany Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Microbiome Therapeutics Market Analysis
-
9.1 APAC Microbiome Therapeutics Market, by Type
-
9.2 APAC Microbiome Therapeutics Market, by Application
-
9.3 APAC Microbiome Therapeutics Market Analysis and Forecast, by Country
-
9.3.1 China Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Microbiome Therapeutics Market Analysis
-
10.1 Latin America, Middle East and Africa Microbiome Therapeutics Market, by Type
-
10.2 Latin America, Middle East and Africa Microbiome Therapeutics Market, by Application
-
10.3 Latin America, Middle East and Africa Microbiome Therapeutics Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Microbiome Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Microbiome Therapeutics Company Profiles
-
11.1 Symbiotix Biotherapies
-
11.1.1 Symbiotix Biotherapies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Symbiotix Biotherapies Microbiome Therapeutics Product Profiles, Application and Specification
-
11.1.3 Symbiotix Biotherapies Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Osel
-
11.2.1 Osel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Osel Microbiome Therapeutics Product Profiles, Application and Specification
-
11.2.3 Osel Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Rebiotix
-
11.3.1 Rebiotix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Rebiotix Microbiome Therapeutics Product Profiles, Application and Specification
-
11.3.3 Rebiotix Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 AOBiome
-
11.4.1 AOBiome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 AOBiome Microbiome Therapeutics Product Profiles, Application and Specification
-
11.4.3 AOBiome Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Seres Therapeutics
-
11.5.1 Seres Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Seres Therapeutics Microbiome Therapeutics Product Profiles, Application and Specification
-
11.5.3 Seres Therapeutics Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Metabogen
-
11.6.1 Metabogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Metabogen Microbiome Therapeutics Product Profiles, Application and Specification
-
11.6.3 Metabogen Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Second Genome
-
11.7.1 Second Genome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Second Genome Microbiome Therapeutics Product Profiles, Application and Specification
-
11.7.3 Second Genome Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Ritter Pharmaceuticals
-
11.8.1 Ritter Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Profiles, Application and Specification
-
11.8.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 OpenBiome
-
11.9.1 OpenBiome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 OpenBiome Microbiome Therapeutics Product Profiles, Application and Specification
-
11.9.3 OpenBiome Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Synthetic Biologics
-
11.10.1 Synthetic Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Synthetic Biologics Microbiome Therapeutics Product Profiles, Application and Specification
-
11.10.3 Synthetic Biologics Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 PureTech
-
11.11.1 PureTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 PureTech Microbiome Therapeutics Product Profiles, Application and Specification
-
11.11.3 PureTech Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Interxon
-
11.12.1 Interxon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Interxon Microbiome Therapeutics Product Profiles, Application and Specification
-
11.12.3 Interxon Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Symberix
-
11.13.1 Symberix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Symberix Microbiome Therapeutics Product Profiles, Application and Specification
-
11.13.3 Symberix Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Metabiomics
-
11.14.1 Metabiomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Metabiomics Microbiome Therapeutics Product Profiles, Application and Specification
-
11.14.3 Metabiomics Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Azitra
-
11.15.1 Azitra Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Azitra Microbiome Therapeutics Product Profiles, Application and Specification
-
11.15.3 Azitra Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 MicroBiome Therapeutics LLC
-
11.16.1 MicroBiome Therapeutics LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Profiles, Application and Specification
-
11.16.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 C3 Jian
-
11.17.1 C3 Jian Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 C3 Jian Microbiome Therapeutics Product Profiles, Application and Specification
-
11.17.3 C3 Jian Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 4D Pharma
-
11.18.1 4D Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 4D Pharma Microbiome Therapeutics Product Profiles, Application and Specification
-
11.18.3 4D Pharma Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Enterome BioScience
-
11.19.1 Enterome BioScience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Enterome BioScience Microbiome Therapeutics Product Profiles, Application and Specification
-
11.19.3 Enterome BioScience Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.20 Assembly Biosciences
-
11.20.1 Assembly Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.20.2 Assembly Biosciences Microbiome Therapeutics Product Profiles, Application and Specification
-
11.20.3 Assembly Biosciences Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.21 Synlogic
-
11.21.1 Synlogic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.21.2 Synlogic Microbiome Therapeutics Product Profiles, Application and Specification
-
11.21.3 Synlogic Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Microbiome Therapeutics Industry Investment Prospect and Risk Assessment
-
12.1 Microbiome Therapeutics Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Microbiome Therapeutics Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Global Microbiome Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure China Microbiome Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure Global Microbiome Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (IBD) (2017-2028)
-
Figure Global Microbiome Therapeutics Market Size and Growth Rate of Orphan Drug (2017-2028)
-
Figure Global Microbiome Therapeutics Market Size and Growth Rate of Immuno-oncology (2017-2028)
-
Figure Global Microbiome Therapeutics Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Microbiome Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (IBD) (2017-2028)
-
Figure Global Microbiome Therapeutics Market Size and Growth Rate of Orphan Drug (2017-2028)
-
Figure Global Microbiome Therapeutics Market Size and Growth Rate of Immuno-oncology (2017-2028)
-
Figure Global Microbiome Therapeutics Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Microbiome Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Microbiome Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Microbiome Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Microbiome Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Microbiome Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Microbiome Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Microbiome Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Microbiome Therapeutics Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Microbiome Therapeutics Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Microbiome Therapeutics Market Share, by Manufacturer in 2021
-
Figure Global and China Microbiome Therapeutics Market Share, by Manufacturer in 2022
-
Table Global Microbiome Therapeutics Sales Volume, by Type (2017-2028)
-
Table Global Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Global Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Global Microbiome Therapeutics Sales Value, by Type (2017-2028)
-
Table Global Microbiome Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure Global Microbiome Therapeutics Price Trend, by Type (2017-2028)
-
Table China Microbiome Therapeutics Sales Volume, by Type (2017-2028)
-
Table China Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure China Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table China Microbiome Therapeutics Sales Value, by Type (2017-2028)
-
Table China Microbiome Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure China Microbiome Therapeutics Price Trend, by Type (2017-2028)
-
Table Global Microbiome Therapeutics Sales Volume, by Application (2017-2028)
-
Table Global Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Global Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table Global Microbiome Therapeutics Sales Value, by Application (2017-2028)
-
Table Global Microbiome Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure Global Microbiome Therapeutics Sales Value Share, by Application (2017-2028)
-
Table China Microbiome Therapeutics Sales Volume, by Application (2017-2028)
-
Table China Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table China Microbiome Therapeutics Sales Value, by Application (2017-2028)
-
Table China Microbiome Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Microbiome Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure North America Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Microbiome Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Table North America Microbiome Therapeutics Sales Volume, by Type (2017-2028)
-
Table North America Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure North America Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table North America Microbiome Therapeutics Sales Volume, by Application (2017-2028)
-
Table North America Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure North America Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure United States Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure United States Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Canada Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Europe Microbiome Therapeutics Sales Volume, by Type (2017-2028)
-
Table Europe Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Europe Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Europe Microbiome Therapeutics Sales Volume, by Application (2017-2028)
-
Table Europe Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Europe Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Germany Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure UK Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure UK Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure France Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure France Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Italy Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Spain Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Poland Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Russia Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table APAC Microbiome Therapeutics Sales Volume, by Type (2017-2028)
-
Table APAC Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure APAC Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table APAC Microbiome Therapeutics Sales Volume, by Application (2017-2028)
-
Table APAC Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure APAC Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Japan Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure India Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure India Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Microbiome Therapeutics Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Microbiome Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Microbiome Therapeutics Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Microbiome Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Microbiome Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Microbiome Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Symbiotix Biotherapies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Symbiotix Biotherapies Product Profiles, Application and Specification
-
Table Symbiotix Biotherapies Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Osel Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Osel Product Profiles, Application and Specification
-
Table Osel Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Rebiotix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Rebiotix Product Profiles, Application and Specification
-
Table Rebiotix Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AOBiome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AOBiome Product Profiles, Application and Specification
-
Table AOBiome Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Seres Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Seres Therapeutics Product Profiles, Application and Specification
-
Table Seres Therapeutics Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Metabogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Metabogen Product Profiles, Application and Specification
-
Table Metabogen Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Second Genome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Second Genome Product Profiles, Application and Specification
-
Table Second Genome Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ritter Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ritter Pharmaceuticals Product Profiles, Application and Specification
-
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table OpenBiome Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table OpenBiome Product Profiles, Application and Specification
-
Table OpenBiome Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Synthetic Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Synthetic Biologics Product Profiles, Application and Specification
-
Table Synthetic Biologics Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table PureTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table PureTech Product Profiles, Application and Specification
-
Table PureTech Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Interxon Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Interxon Product Profiles, Application and Specification
-
Table Interxon Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Symberix Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Symberix Product Profiles, Application and Specification
-
Table Symberix Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Metabiomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Metabiomics Product Profiles, Application and Specification
-
Table Metabiomics Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Azitra Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Azitra Product Profiles, Application and Specification
-
Table Azitra Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table MicroBiome Therapeutics LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table MicroBiome Therapeutics LLC Product Profiles, Application and Specification
-
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table C3 Jian Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table C3 Jian Product Profiles, Application and Specification
-
Table C3 Jian Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table 4D Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table 4D Pharma Product Profiles, Application and Specification
-
Table 4D Pharma Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Enterome BioScience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Enterome BioScience Product Profiles, Application and Specification
-
Table Enterome BioScience Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Assembly Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Assembly Biosciences Product Profiles, Application and Specification
-
Table Assembly Biosciences Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Synlogic Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Synlogic Product Profiles, Application and Specification
-
Table Synlogic Microbiome Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
